Caroline Sarah Stokes
Caroline Sarah Stokes
Verified email at hu-berlin.de
Title
Cited by
Cited by
Year
Omega-3 fatty acids in the treatment of psychiatric disorders
M Peet, C Stokes
Drugs 65 (8), 1051-1059, 2005
3452005
Dietary fibre and health: an overview
JL Buttriss, CS Stokes
Nutrition Bulletin 33 (3), 186-200, 2008
2542008
Vitamin D in chronic liver disease
CS Stokes, DA Volmer, F Grünhage, F Lammert
Liver International 33 (3), 338-352, 2013
1492013
No effect of a diet with a reduced glycaemic index on satiety, energy intake and body weight in overweight and obese women
LM Aston, CS Stokes, SA Jebb
International Journal of Obesity 32 (1), 160-165, 2008
1252008
Analysis of vitamin D metabolic markers by mass spectrometry: current techniques, limitations of the “gold standard” method, and anticipated future directions
DA Volmer, LRBC Mendes, CS Stokes
Mass spectrometry reviews 34 (1), 2-23, 2015
942015
Gallstones: environment, lifestyle and genes
CS Stokes, M Krawczyk, F Lammert
Digestive Diseases 29 (2), 191-201, 2011
892011
Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials
CS Stokes, LL Gluud, M Casper, F Lammert
Clinical Gastroenterology and Hepatology 12 (7), 1090-1100. e2, 2014
842014
Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis
CS Stokes, M Krawczyk, C Reichel, F Lammert, F Grünhage
European journal of clinical investigation 44 (2), 176-183, 2014
572014
Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms.
C Stokes, M Peet
Nutritional neuroscience 7 (4), 247-249, 2004
542004
The role of diet in the prevention and management of adolescent depression
DJ Bamber, CS Stokes, AM Stephen
Nutrition Bulletin 32, 90-99, 2007
452007
L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
ET Goh, CS Stokes, SS Sidhu, H Vilstrup, LL Gluud, MY Morgan
Cochrane Database of Systematic Reviews, 2018
432018
Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease
CS Stokes, F Grünhage, C Baus, DA Volmer, S Wagenpfeil, ...
Clinical nutrition 35 (4), 950-957, 2016
402016
Effect of short-term vitamin D correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP)
I Papapostoli, F Lammert, CS Stokes
J Gastrointestin Liver Dis 25 (2), 175-81, 2016
372016
HCC and liver disease risks in homozygous PNPLA3 p. I148M carriers approach monogenic inheritance
M Krawczyk, CS Stokes, S Romeo, F Lammert
Journal of hepatology 62 (4), 980-981, 2015
332015
Aktualisierte S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein-und …
C Gutt, C Jenssen, AP Barreiros, TO Götze, CS Stokes, PL Jansen, ...
Zeitschrift für Gastroenterologie 56 (08), 912-966, 2018
312018
Chemotyping the distribution of vitamin D metabolites in human serum
MJ Müller, CS Stokes, F Lammert, DA Volmer
Scientific reports 6 (1), 1-9, 2016
292016
Vitamin D supplementation: less controversy, more guidance needed
CS Stokes, F Lammert
F1000Research 5, 2016
292016
Vitamin D modulates biliary fibrosis in ABCB4-deficient mice
K Hochrath, CS Stokes, J Geisel, MJ Pollheimer, P Fickert, S Dooley, ...
Hepatology international 8 (3), 443-452, 2014
272014
The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP)
A Arslanow, CS Stokes, SN Weber, F Grünhage, F Lammert, M Krawczyk
Liver International 36 (3), 418-426, 2016
262016
Transporters in cholelithiasis
CS Stokes, F Lammert
Biological chemistry 393 (1-2), 3-10, 2012
252012
The system can't perform the operation now. Try again later.
Articles 1–20